Brendon L Neuen

72PUBLICATIONS
178CO-AUTHORS
Pharmaceutical delivery technologiesNeurology and neuromuscular diseasesMolecular targetsMolecular medicineCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (72)

|Jul 28, 2026
Trends in publicly subsidized and private access to GLP-1 medicines indicated for type 2 diabetes in Australia, 2020-2025.

|Jul 16, 2026
Non-diabetic kidney disease in patients with diabetes undergoing native kidney biopsy.

|Jun 23, 2026
A Framework for Risk-Based Implementation of Combination Therapy in CKD: Who, Why, When, and How?

|Jun 02, 2026
A Dose of Perspective: A Multinational Survey of Patient and Clinician Views on Combination Therapy in CKD.

|May 15, 2026
Iron deficiency and risk of heart failure and cardiovascular events in CKD: Insights from the ASCEND-ND trial.

|Apr 06, 2026
Is Placebo Still Ethical in Trials of Incretin Therapies?

Brendon L Neuen, John W Ostrominski, Muthiah Vaduganathan

Pageof 12

Frequent Collaborators

32 joint publications

Hiddo Jl Heerspink

29 joint publications

Clare Arnott

18 joint publications

Bruce Neal

16 joint publications

Muthiah Vaduganathan